Carol L. Chen

3.0k total citations · 1 hit paper
13 papers, 1.3k citations indexed

About

Carol L. Chen is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Oncology. According to data from OpenAlex, Carol L. Chen has authored 13 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 5 papers in Cardiology and Cardiovascular Medicine and 4 papers in Oncology. Recurrent topics in Carol L. Chen's work include Amyloidosis: Diagnosis, Treatment, Outcomes (4 papers), Neuroendocrine Tumor Research Advances (3 papers) and Chemotherapy-induced cardiotoxicity and mitigation (3 papers). Carol L. Chen is often cited by papers focused on Amyloidosis: Diagnosis, Treatment, Outcomes (4 papers), Neuroendocrine Tumor Research Advances (3 papers) and Chemotherapy-induced cardiotoxicity and mitigation (3 papers). Carol L. Chen collaborates with scholars based in United States, Belgium and Canada. Carol L. Chen's co-authors include Syed Mahmood, Rongras Damrongwatanasuk, Sachin Shah, Lucie Heinzerling, Paaladinesh Thavendiranathan, Magid Awadalla, Michael G. Fradley, Justine V. Cohen, Michael Constantin Kirchberger and Malek Hassan and has published in prestigious journals such as Journal of Clinical Oncology, Journal of the American College of Cardiology and Journal of the American Society of Echocardiography.

In The Last Decade

Carol L. Chen

12 papers receiving 1.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Myocarditis in Patients Treated With Immune Checkpoint Inhibitors

2018 1.1k citations Syed Mahmood, Michael G. Fradley et al. Journal of the American College of Cardiology profile →

Peers

Carol L. Chen

ONCOL

CCM

PRM

MB

RNMI

Douglas B. Johnson United States

Rongras Damrongwatanasuk United States

Robert F. Cornell United States

Jonathan H. Goldman United States

Yat Yin Lam Hong Kong

Takahide Kodama Japan

Monika Leja United States

Takahiro Nishida Japan

Eleonora Arboscello Italy

Christoph Schukro Austria

Douglas B. Johnson United States

Carol L. Chen

1.1k ×1.3

ONCOL

536 ×0.9

CCM

235 ×1.1

PRM

160 ×0.8

MB

119 ×0.8

RNMI

Citations per year, relative to Carol L. Chen Carol L. Chen (= 1×) peers Douglas B. Johnson

Countries citing papers authored by Carol L. Chen

Since Specialization

Citations

This map shows the geographic impact of Carol L. Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carol L. Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carol L. Chen more than expected).

Fields of papers citing papers by Carol L. Chen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carol L. Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carol L. Chen. The network helps show where Carol L. Chen may publish in the future.

Co-authorship network of co-authors of Carol L. Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Carol L. Chen. A scholar is included among the top collaborators of Carol L. Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carol L. Chen. Carol L. Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

1.

Yu, Anthony F., Heather Landau, Xiaoyue Ma, et al.. (2025). Improvement in global longitudinal strain following plasma cell-directed therapy is associated with long-term survival among patients with AL amyloidosis. European Heart Journal Open. 5(5). oeaf104–oeaf104.

2.

Yu, Anthony F., Chau T. Dang, Chaya S. Moskowitz, et al.. (2025). Cardiac Safety of Reduced Cardiotoxicity Surveillance During HER2-Targeted Therapy. JACC CardioOncology. 7(4). 430–441. 4 indexed citations

3.

Dika, Imane El, Jinru Shia, Carol L. Chen, et al.. (2022). Congenital cardiac liver cirrhosis with combined hepatocellular-cholangiocarcinoma—a case report. Journal of Gastrointestinal Oncology. 13(6). 3321–3328. 1 indexed citations

4.

Chuy, Katherine Lee, Heather Landau, Hani Hassoun, et al.. (2020). INCREMENTAL VALUE OF GLS FOR CLASSIFICATION OF PROGNOSIS IN PATIENTS WITH ADVANCED LIGHT CHAIN (AL) AMYLOIDOSIS. Journal of the American College of Cardiology. 75(11). 1006–1006. 1 indexed citations

5.

Chuy, Katherine Lee, Esther Drill, Heather Landau, et al.. (2020). Incremental Value of Global Longitudinal Strain for Predicting Survival in Patients With Advanced AL Amyloidosis. JACC CardioOncology. 2(2). 223–231. 34 indexed citations

6.

Sobol, Irina, Carol L. Chen, Syed Mahmood, & Alain Borczuk. (2020). Histopathologic Characterization of Myocarditis Associated With Immune Checkpoint Inhibitor Therapy. Archives of Pathology & Laboratory Medicine. 144(11). 1392–1396. 41 indexed citations

7.

Mahmood, Syed, Michael G. Fradley, Justine V. Cohen, et al.. (2018). Myocarditis in Patients Treated With Immune Checkpoint Inhibitors. Journal of the American College of Cardiology. 71(16). 1755–1764. 1050 indexed citations breakdown →

8.

Mahmood, Syed, Carol L. Chen, Natalie Shapnik, et al.. (2018). Myocarditis with tremelimumab plus durvalumab combination therapy for endometrial cancer: A case report. Gynecologic Oncology Reports. 25. 74–77. 44 indexed citations

9.

Ip, James E., et al.. (2017). Asystole during pacemaker magnet application. Pacing and Clinical Electrophysiology. 40(10). 1176–1179. 1 indexed citations

10.

Landau, Heather, Elyn Riedel, Anthony F. Yu, et al.. (2017). Prognostic and Added Value of Two-Dimensional Global Longitudinal Strain for Prediction of Survival in Patients with Light Chain Amyloidosis Undergoing Autologous Hematopoietic Cell Transplantation. Journal of the American Society of Echocardiography. 31(1). 64–70. 39 indexed citations

11.

Chen, Carol L.. (2015). Cardiovascular Prevention in the Cancer Survivor. Current Atherosclerosis Reports. 17(3). 484–484. 10 indexed citations

12.

Khan, Shaheer, Carol L. Chen, Mary S. Brady, et al.. (2012). Unstable Angina Associated With Cisplatin and Carboplatin in a Patient With Advanced Melanoma. Journal of Clinical Oncology. 30(18). e163–e164. 24 indexed citations

13.

Chen, Carol L., et al.. (2011). Cardiac Disease and Heart Failure in Cancer Patients: Is Our Training Adequate to Provide Optimal Care?. Heart Failure Clinics. 7(3). 357–362. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact